
Theravance Biopharma, Inc.
USD15.92
+0.34 (+2.18%)
CEO
Rick E. Winningham
IPO Date
2014-05-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
KY
Open
$15.65
Prev. Close
$15.58
Day Low
$15.65
Day High
$16.18
52W Low
$10.42
52W High
$21.03
Market Cap
$0.82B
Volume
0.33M
| 5 Mar 2026 |
| Oppenheimer |
| Outperform |
| Perform |
| downgrade |
| 4 Mar 2026 | B. Riley Securities | Buy | Neutral | downgrade |
| 4 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 3 Mar 2026 | BTIG | Buy | Buy | maintain |
| 2 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 3 Feb 2026 | BTIG | Buy | Buy | maintain |
| 26 Nov 2025 | BTIG | Buy | Buy | maintain |